PIPA5104288
ZNF839 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5104288-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA5104288 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
ZNF839
Classification
Polyclonal
Conjugate
Unconjugated
Gene
ZNF839
Gene Alias
C14orf131; renal carcinoma antigen NY-REN-50; Zinc finger protein 839; ZNF839
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
55778
Content And Storage
-20°C
Form
Liquid
Applications
Immunohistochemistry (Paraffin), Western Blot
Concentration
1 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.
A8K0R7
Gene Symbols
ZNF839
Immunogen
A synthesized peptide derived from human ZNF839(Accession A8K0R7), corresponding to amino acid residues N434-A484.
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Antibody detects endogenous levels of total ZNF839
- ZNF839, also known as C14orf131, is an 811 amino acid protein that contains one C2H2-type zinc finger
- The gene encoding ZNF839 localizes to chromosome 14 and, due to alternative splicing events, four ZNF839 isoforms are expressed
- Chromosome 14 contains about 700 genes and 106 million base pairs and makes up about 3.5% of human cellular DNA
- Chromosome 14 encodes the presinilin 1 (PSEN1) gene, which is one of the three key genes associated with the development of Alzheimer's disease
- The SERPINA1 gene is located on chromosome 14 and when defective leads to the genetic disorder alpha1-antitrypsin deficiency
- This disorder is characterized by severe lung complications and liver dysfunction
- Notably, the immunoglobulin heavy chain locus is found on chromosome 14 and has been identified as a fusion with the chromosome 19 encoded protein BCL3 in the (14; 19) translocations found in a variety of B cell malignancies.